Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation - PubMed (original) (raw)

Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation

G W Demers et al. J Virol. 1996 Oct.

Abstract

Cells arrest in the G1 or G0 phase of the cell cycle in response to a variety of negative growth signals that induce arrest by different molecular pathways. The ability of human papillomavirus (HPV) oncogenes to bypass these signals and allow cells to progress into the S phase probably contributes to the neoplastic potential of the virus. The E7 protein of HPV-16 was able to disrupt the response of epithelial cells to three different negative growth arrest signals: quiescence imposed upon suprabasal epithelial cells, G1 arrest induced by DNA damage, and inhibition of DNA synthesis caused by treatment with transforming growth factor beta. The same set of mutated E7 proteins was able to abrogate all three growth arrest signals. Mutant proteins that failed to abrogate growth arrest signals were transformation deficient and included E7 proteins that bound retinoblastoma protein in vitro. In contrast, HPV-16 E6 was able to bypass only DNA damage-induced G1 arrest, not suprabasal quiescence or transforming growth factor beta-induced arrest. The E6 and E7 proteins from the low-risk virus HPV-6 were not able to bypass any of the growth arrest signals.

PubMed Disclaimer

Cited by

Genome composition-based deep learning predicts oncogenic potential of HPVs.
Hao L, Jiang Y, Zhang C, Han P. Hao L, et al. Front Cell Infect Microbiol. 2024 Jul 22;14:1430424. doi: 10.3389/fcimb.2024.1430424. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39104853 Free PMC article.
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.
Wang J, Calizo A, Zhang L, Pino JC, Lyu Y, Pollard K, Zhang X, Larsson AT, Conniff E, Llosa NJ, Wood DK, Largaespada DA, Moody SE, Gosline SJ, Hirbe AC, Pratilas CA. Wang J, et al. Sci Adv. 2023 Nov 24;9(47):eadg8876. doi: 10.1126/sciadv.adg8876. Epub 2023 Nov 24. Sci Adv. 2023. PMID: 38000020 Free PMC article.
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon restoration of RB function in malignant peripheral nerve sheath tumors.
Wang J, Calizo A, Zhang L, Pino JC, Lyu Y, Pollard K, Zhang X, Larsson AT, Conniff E, Llosa N, Wood DK, Largaespada DA, Moody SE, Gosline SJ, Hirbe AC, Pratilas CA. Wang J, et al. bioRxiv [Preprint]. 2023 Feb 3:2023.02.02.526674. doi: 10.1101/2023.02.02.526674. bioRxiv. 2023. PMID: 36778419 Free PMC article. Updated. Preprint.
Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell-like Program Conserved in HPV-Positive Cancers.
Leiendecker L, Neumann T, Jung PS, Cronin SM, Steinacker TL, Schleiffer A, Schutzbier M, Mechtler K, Kervarrec T, Laurent E, Bachiri K, Coyaud E, Murali R, Busam KJ, Itzinger-Monshi B, Kirnbauer R, Cerroni L, Calonje E, Rütten A, Stubenrauch F, Griewank KG, Wiesner T, Obenauf AC. Leiendecker L, et al. Cancer Discov. 2023 Jan 9;13(1):70-84. doi: 10.1158/2159-8290.CD-22-0489. Cancer Discov. 2023. PMID: 36213965 Free PMC article.
Construction and immune effect of an HPV16/18/58 trivalent therapeutic adenovirus vector vaccine.
Wan B, Qin L, Ma W, Wang H. Wan B, et al. Infect Agent Cancer. 2022 Feb 23;17(1):5. doi: 10.1186/s13027-022-00417-3. Infect Agent Cancer. 2022. PMID: 35197089 Free PMC article.

References

1. J Virol. 1991 Jan;65(1):473-8 - PubMed
1. Nature. 1994 Sep 15;371(6494):257-61 - PubMed
1. J Virol. 1991 Jul;65(7):3943-8 - PubMed
1. Cell. 1991 Jun 14;65(6):1053-61 - PubMed
1. Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5187-91 - PubMed

Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation - PubMed (original) (raw)